Emma Duffield
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 0.2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Lung Cancer Diagnosis and Treatment 3
- Gastric Cancer Management and Outcomes 3
- Oncology 14
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 8
- Co-authors
- Alison Armour (8 shared papers)Nagahiro Saijo (5 shared papers)Tony Mok (9 shared papers)Masahiro Fukuoka (5 shared papers)Haiyi Jiang (5 shared papers)James Chih‐Hsin Yang (4 shared papers)Yi‐Long Wu (6 shared papers)Sumitra Thongprasert (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Thoracic Oncology (5 papers)Atherosclerosis Supplements (2 papers)Cardiology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United KingdomHong KongJapan
In The Last Decade
Emma Duffield
21 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pulmonary and Respiratory Medicine 7.2k
- Oncology 5.7k
- Cancer Research 2.1k
- Molecular Biology 2.1k
- Pathology and Forensic Medicine 442
Countries citing papers authored by Emma Duffield
This map shows the geographic impact of Emma Duffield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Duffield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Duffield more than expected).
Fields of papers citing papers by Emma Duffield
This network shows the impact of papers produced by Emma Duffield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Duffield. The network helps show where Emma Duffield may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Duffield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma Hit paper breakdown → | 2009 | 6355 |
| 2 | Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS) Hit paper breakdown → | 2011 | 1180 |
| 3 | 2008 | 176 | |
| 4 | 2011 | 173 | |
| 5 | 2007 | 161 | |
| 6 | 2011 | 107 | |
| 7 | 2009 | 96 | |
| 8 | 2009 | 95 | |
| 9 | 2012 | 38 | |
| 10 | 2008 | 27 | |
| 11 | 2007 | 19 | |
| 12 | 2007 | 15 | |
| 13 | 2007 | 12 | |
| 14 | 2009 | 10 | |
| 15 | 2009 | 8 | |
| 16 | 2011 | 5 | |
| 17 | 2006 | 5 | |
| 18 | 2009 | 3 | |
| 19 | 2006 | 3 | |
| 20 | Oskira-3: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To a Tumor Necrosis Factor-alpha Antagonist | 2013 | 1 |
About Emma Duffield
Emma Duffield is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Economics and Econometrics, having authored 21 papers that have together received 8.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Research Studies (8 papers), Lipoproteins and Cardiovascular Health (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.2k citations), Oncology (5.7k citations), Cancer Research (2.1k citations), Molecular Biology (2.1k citations) and Pathology and Forensic Medicine (442 citations). Emma Duffield has collaborated with scholars based in United Kingdom, Hong Kong and Japan. Frequent co-authors include Alison Armour, Nagahiro Saijo, Tony Mok, Masahiro Fukuoka, Haiyi Jiang, James Chih‐Hsin Yang, Yi‐Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong and Yukito Ichinose. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Atherosclerosis Supplements, Cardiology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.